BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6208992)

  • 1. Progress toward therapeutic application of interferons, 1979-1983.
    Borden EC
    Cancer; 1984 Dec; 54(11 Suppl):2770-6. PubMed ID: 6208992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The actions of interferon are potentiated at elevated temperature.
    Heron I; Berg K
    Nature; 1978 Aug; 274(5670):508-10. PubMed ID: 307691
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferons with special emphasis on the immune system.
    Friedman RM; Vogel SN
    Adv Immunol; 1983; 34():97-140. PubMed ID: 6195895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon treatment of human neoplasia.
    Strander H
    Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action.
    Chen HY; Sato T; Fuse A; Kuwata T; Content J
    J Gen Virol; 1981 Jan; 52(Pt 1):177-81. PubMed ID: 6167662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does interferon inhibit tumour growth?
    Gresser I
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):69-76. PubMed ID: 6183697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy with interferons in blood diseases.
    Polli E; Cortelezzi A
    Acta Haematol; 1987; 78 Suppl 1():64-9. PubMed ID: 2449025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon: a perspective.
    Weissman RM; Droller MJ
    Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferon: facts and hopes. I. Properties of interferon].
    Dmoszyńska-Giannopoulou A; Rupniewska ZM
    Pol Arch Med Wewn; 1981 Oct; 66(4):303-6. PubMed ID: 6174953
    [No Abstract]   [Full Text] [Related]  

  • 11. Human natural killer cells.
    Trinchieri G; Perussia B; Santoli D; Cerottini JC
    Transplant Proc; 1979 Mar; 11(1):807-10. PubMed ID: 452106
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients.
    Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E
    Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression of natural killer cell activity by interferon.
    Ho M; White LT; Haverkos HW; Breinig MC; Pazin GJ; Armstrong JA
    J Infect Dis; 1981 Dec; 144(6):605. PubMed ID: 6173448
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro interactions of purified cloned human interferons on NK cells: enhanced activation.
    Targan S; Stebbing N
    J Immunol; 1982 Sep; 129(3):934-5. PubMed ID: 6180004
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferons in the treatment of human cancer.
    Kirkwood JM; Ernstoff MS
    J Clin Oncol; 1984 Apr; 2(4):336-52. PubMed ID: 6323641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of interferons inhibitory effect on cell growth by the mitogenic stimulus.
    Taylor-Papadimitriou J; Rozengurt E
    Tex Rep Biol Med; 1981-1982; 41():509-16. PubMed ID: 6189216
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RR; Ortaldo JR; Bonnard GD
    Nature; 1979 Jan; 277(5693):221-3. PubMed ID: 95205
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biological immunomodulators in the treatment of cancer].
    Bello C; Richard C; Hermosa V; Iriondo A; Muruzábal MJ; Pérez Encinas M; Zubizarreta A
    Sangre (Barc); 1988 Apr; 33(2):132-43. PubMed ID: 2456623
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
    Fuggetta MP; D'Onofrio C; Bonmassar E
    Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered natural killer cell response in patients with malignant lymphoma.
    Hawrylowicz CM; Rees RC; Potter CW; Hancock BW
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):141-4. PubMed ID: 6183691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.